AHA Scientific Sessions 2026 Abstract · Nov 2, 2026
Defining Optimal Storage Parameters for Heart Valve Transplantation
By Alfieri C, Faateh M, Molkentin JD et al.
Significance: Living allogeneic valve transplant (LAVT) is a novel surgical procedure that involves transplantation of viable human valves. LAVT represents a paradigm shift in surgical management of pediatric heart valve disease due to the potential for growth, self-repair and avoidance of valve reoperations. Major barriers to the widespread implementation of LAVT are logistical/storage concerns which are currently similar to an orthotopic heart transplant (maximum graft cold ischemia time of 4-6 hours). Hypothesis: Semilunar heart valves may have a greater ischemic tolerance (relative to myocardium) due to their lower metabolic needs and may be able to withstand a longer period of cold preservation. Methods: Aortic and pulmonary leaflets were harvested from discarded porcine hearts at the time of slaughter (mixed sex animals, 95-105 kg). Leaflets were statically stored in standard of care University of Wisconsin (UW) solution at 4°C, 10°C, or 22°C, with phosphate-buffered saline (PBS) used as a 22 °C control. Separately, viable human semilunar valve leaflets were collected from a discarded explanted pediatric heart. These were stored statically in UW or PBS at 10°C or 22°C for 4 weeks. For both human and porcine samples, viability was assessed weekly using the Alamar Blue assay for up to 4 weeks and normalized to dry tissue weight. Results: In porcine leaflets statically stored there was approximately a 75% decline in viability at 2 weeks for leaflets stored in PBS at 22°C and this continued to decline through 4 weeks. In contrast, leaflets stored in UW solution at 4°C and 10°C, maintained viability throughout the study period. Human valve leaflet viability was maintained for the full 4-week period only in UW solution at 10°C. At 22°C, PBS stored leaflets demonstrated an almost total loss of viability after 1 week while the UW stored leaflets showed high viability loss after 2 weeks. (Figure) Conclusions: Cardiac valve tissue viability can be maintained for up to 4 weeks in both porcine and human leaflets during static storage in University of Wisconsin solution at 10°C, far beyond the allowed duration for an orthotopic heart transplant. These findings support the possibility for biobanking and increasing adoption for LAVT.